Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
468.08
-4.63 (-0.98%)
Mar 18, 2026, 11:50 AM EDT - Market open
Revenue Breakdown
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 27, 2025 | Jun '25 Jun 28, 2025 | Mar '25 Mar 29, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 28, 2024 | Jun '24 Jun 29, 2024 | Mar '24 Mar 30, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jul '23 Jul 1, 2023 | Apr '23 Apr 1, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 1, 2022 | Jul '22 Jul 2, 2022 | Apr '22 Apr 2, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 2, 2021 | Jul '21 Jul 3, 2021 | Apr '21 Apr 3, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 26, 2020 | Jun '20 Jun 27, 2020 | Mar '20 Mar 28, 2020 |
Life Sciences Solutions Revenue | 2.95B | |||||||||||||||||||||||
Life Sciences Solutions Revenue Growth | 13.13% | |||||||||||||||||||||||
Analytical Instruments Revenue | 2.22B | |||||||||||||||||||||||
Analytical Instruments Revenue Growth | 1.33% | |||||||||||||||||||||||
Specialty Diagnostics Revenue | 1.22B | |||||||||||||||||||||||
Specialty Diagnostics Revenue Growth | 5.45% | |||||||||||||||||||||||
Laboratory Products and Biopharma Services Revenue | 6.38B | |||||||||||||||||||||||
Laboratory Products and Biopharma Services Revenue Growth | 7.46% | |||||||||||||||||||||||
Revenue (Other) | -545.00M | |||||||||||||||||||||||
Revenue (Total) | 12.22B | |||||||||||||||||||||||
Revenue (Total) Growth | 7.20% |
Revenue Breakdown 2
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 27, 2025 | Jun '25 Jun 28, 2025 | Mar '25 Mar 29, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 28, 2024 | Jun '24 Jun 29, 2024 | Mar '24 Mar 30, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jul '23 Jul 1, 2023 | Apr '23 Apr 1, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 1, 2022 | Jul '22 Jul 2, 2022 | Apr '22 Apr 2, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 2, 2021 | Jul '21 Jul 3, 2021 | Apr '21 Apr 3, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 26, 2020 | Jun '20 Jun 27, 2020 | Mar '20 Mar 28, 2020 |
Consumables Revenue | 5.03B | |||||||||||||||||||||||
Consumables Revenue Growth | 11.25% | |||||||||||||||||||||||
Instruments Revenue | 2.22B | |||||||||||||||||||||||
Instruments Revenue Growth | -1.33% | |||||||||||||||||||||||
Services Revenue | 4.97B | |||||||||||||||||||||||
Services Revenue Growth | 7.41% | |||||||||||||||||||||||
Revenue (Total) | 12.22B | |||||||||||||||||||||||
Revenue (Total) Growth | 7.20% |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 27, 2025 | Jun '25 Jun 28, 2025 | Mar '25 Mar 29, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 28, 2024 | Jun '24 Jun 29, 2024 | Mar '24 Mar 30, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jul '23 Jul 1, 2023 | Apr '23 Apr 1, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 1, 2022 | Jul '22 Jul 2, 2022 | Apr '22 Apr 2, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 2, 2021 | Jul '21 Jul 3, 2021 | Apr '21 Apr 3, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 26, 2020 | Jun '20 Jun 27, 2020 | Mar '20 Mar 28, 2020 |
North America Revenue | 6.11B | |||||||||||||||||||||||
North America Revenue Growth | 4.16% | |||||||||||||||||||||||
Europe Revenue | 3.37B | |||||||||||||||||||||||
Europe Revenue Growth | 16.55% | |||||||||||||||||||||||
Asia-Pacific Revenue | 2.28B | |||||||||||||||||||||||
Asia-Pacific Revenue Growth | 3.45% | |||||||||||||||||||||||
Other Regions Revenue | 462.00M | |||||||||||||||||||||||
Other Regions Revenue Growth | 5.24% | |||||||||||||||||||||||
Revenue (Total) | 12.22B | |||||||||||||||||||||||
Revenue (Total) Growth | 7.20% |
EBIT
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 27, 2025 | Jun '25 Jun 28, 2025 | Mar '25 Mar 29, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 28, 2024 | Jun '24 Jun 29, 2024 | Mar '24 Mar 30, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jul '23 Jul 1, 2023 | Apr '23 Apr 1, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 1, 2022 | Jul '22 Jul 2, 2022 | Apr '22 Apr 2, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 2, 2021 | Jul '21 Jul 3, 2021 | Apr '21 Apr 3, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 26, 2020 | Jun '20 Jun 27, 2020 | Mar '20 Mar 28, 2020 |
Life Sciences Solutions Operating Income | 1.05B | |||||||||||||||||||||||
Life Sciences Solutions Operating Income Growth | 9.87% | |||||||||||||||||||||||
Analytical Instruments Operating Income | 583.00M | |||||||||||||||||||||||
Analytical Instruments Operating Income Growth | -12.46% | |||||||||||||||||||||||
Specialty Diagnostics Operating Income | 324.00M | |||||||||||||||||||||||
Specialty Diagnostics Operating Income Growth | 18.68% | |||||||||||||||||||||||
Laboratory Products and Biopharma Services Operating Income | 925.00M | |||||||||||||||||||||||
Laboratory Products and Biopharma Services Operating Income Growth | 11.71% | |||||||||||||||||||||||
Operating Income (Other) | -623.00M | |||||||||||||||||||||||
Operating Income (Total) | 2.26B | |||||||||||||||||||||||
Operating Income (Total) Growth | 11.86% |
Key Performance Indicators
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 27, 2025 | Jun '25 Jun 28, 2025 | Mar '25 Mar 29, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 28, 2024 | Jun '24 Jun 29, 2024 | Mar '24 Mar 30, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jul '23 Jul 1, 2023 | Apr '23 Apr 1, 2023 | Dec '22 Dec 31, 2022 | Oct '22 Oct 1, 2022 | Jul '22 Jul 2, 2022 | Apr '22 Apr 2, 2022 | Dec '21 Dec 31, 2021 | Oct '21 Oct 2, 2021 | Jul '21 Jul 3, 2021 | Apr '21 Apr 3, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 26, 2020 | Jun '20 Jun 27, 2020 | Mar '20 Mar 28, 2020 |
Total Organic Revenue Growth | 3.00% |
Updated Jan 29, 2026. Data Source: Fiscal.ai.